The Discounted Cash Flow (DCF) valuation of Tianjin TEDA Biomedical Engineering Co Ltd (8189.HK) is 0.26 HKD. With the latest stock price at 0.48 HKD, the upside of Tianjin TEDA Biomedical Engineering Co Ltd based on DCF is -45.7%.
Based on the latest price of 0.48 HKD and our DCF valuation, Tianjin TEDA Biomedical Engineering Co Ltd (8189.HK) is a sell. selling 8189.HK stocks now will result in a potential gain of 45.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 9.7% | 8.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.15 - 0.56 | 0.26 |
| Upside | -68.1% - 15.7% | -45.7% |